Rothschild & CO Asset Management Us Inc. Atri Cure, Inc. Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 84,504 shares of ATRC stock, worth $2.88 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
84,504
Previous 85,279
0.91%
Holding current value
$2.88 Million
Previous $3.33 Million
12.48%
% of portfolio
0.06%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding ATRC
# of Institutions
223Shares Held
52.2MCall Options Held
33.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.91MShares$167 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$157 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.97MShares$135 Million0.02% of portfolio
-
Alliancebernstein L.P. New York, NY3.57MShares$122 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.06MShares$104 Million1.62% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.58B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...